<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To detect the relationship between ApoE gene polymorphism and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>(CHD), arteriosclerotic <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>(ACI) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Exon 4 of ApoE gene was analyzed in <z:mpath ids='MPATH_458'>normal</z:mpath> group(87 cases), CHD group(78 cases) and ACI group(55 cases) by a combination of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct AgNO(3) staining technique </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Between the control group and CHD group, ACI group, chi(2) test showed no significant difference in genotype of E3/E3 (P&gt;0.5, P&gt;0.1, respectively); while mu test showed no significant difference in allele epsilon(2)(P&gt;0.25, P&gt;0.1, respectively), epsilon(4)(P&gt;0.1, P&gt;0.25, respectively) of ApoE </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: No relationship between ApoE gene polymorphism and CHD and ACI was noted in this study </plain></SENT>
</text></document>